These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6812709)

  • 21. ELISA for occult faecal albumin.
    Nakayama T; Yasuoka H; Kishino T; Ohguchi H; Takada M
    Lancet; 1987 Jun; 1(8546):1368-9. PubMed ID: 2884469
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients.
    Pye G; Jackson J; Thomas WM; Hardcastle JD
    Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of faecal occult blood using chlorpromazine as reagent.
    Seet AM; Goh TC
    Clin Chim Acta; 1972 Nov; 42(1):209-10. PubMed ID: 4631983
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of faecal occult blood loss by qualitative and quantitative methods.
    Barber MD; Abraham A; Brydon WG; Waldron BM; Williams AJ
    J R Coll Surg Edinb; 2002 Apr; 47(2):491-4. PubMed ID: 12018693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
    Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
    Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
    Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
    Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.
    Hall C; Griffin J; Dykes PW; Williams JA; Keighley MR
    Gut; 1993 Feb; 34(2):227-9. PubMed ID: 8432478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of faecal occult blood using A.B.T.S. as reagent.
    Deadman NM
    Clin Chim Acta; 1973 Nov; 48(4):433-4. PubMed ID: 4761591
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal occult blood testing in symptomatic patients: comparison of three tests.
    Tate JJ; Northway J; Royle GT; Taylor I
    Br J Surg; 1990 May; 77(5):523-6. PubMed ID: 2354334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing of feces for occult blood: a review.
    Lauridsen LH; Bohn L
    Dan Med Bull; 1976 Oct; 23(5):230-5. PubMed ID: 975943
    [No Abstract]   [Full Text] [Related]  

  • 32. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
    Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
    Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Patient with stomach polyps--a risk group for colorectal tumors? Haemoccult studies on 106 patients].
    Liebe S; Wohlgemuth B
    Z Gesamte Inn Med; 1981 Sep; 36(18):682-4. PubMed ID: 7314752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with haemoccult screening in Hungary. A multicenter trial.
    Siba S
    Hepatogastroenterology; 1983 Feb; 30(1):27-9. PubMed ID: 6601046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Whole body 59Fe elimination determination is more reliable and sensitive than Haemoccult test as demonstration and quantification of occult blood in feces].
    Heinrich HC
    Dtsch Med Wochenschr; 1978 Apr; 103(17):753. PubMed ID: 648341
    [No Abstract]   [Full Text] [Related]  

  • 37. Enteric alpha-1-antitrypsin loss and comparison with Okokit II and Haemoccult for the detection of colorectal cancer.
    Moran A; Hendrickse C; Jones AF; Neoptolemos J
    Surg Oncol; 1994 Jun; 3(3):147-51. PubMed ID: 7952398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Early detection of colonic and rectal cancer; extensive study of occult blood].
    Jorge AD; Sánchez D; Díaz M; Lorenzo J; Milutin C
    Acta Gastroenterol Latinoam; 1977 Dec; 7(4):261-8. PubMed ID: 310229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal faecal blood loss after injection of 51Cr-labelled red cells.
    O'Neill BJ; Shum HY; Streeter AM
    Lancet; 1973 Aug; 2(7823):262. PubMed ID: 4124451
    [No Abstract]   [Full Text] [Related]  

  • 40. Fecal occult blood testing.
    Van Strien A
    CA Cancer J Clin; 1982; 32(6):370-1. PubMed ID: 6812898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.